Orgenesis just reported results for the second quarter of 2024. More
Articles
KRON Stock Earnings: Kronos Bio Beats EPS, Beats Revenue for Q2 2024
KRON stock results show that Kronos Bio beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
LOGC Stock Earnings: ContextLogic Misses EPS, Beats Revenue for Q2 2024
LOGC stock results show that ContextLogic missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. More
MIST Stock Earnings: Milestone Pharmaceuticals Beats EPS for Q2 2024
MIST stock results show that Milestone Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024. More
INTS Stock Earnings: Intensity Therapeutics Misses EPS for Q2 2024
INTS stock results show that Intensity Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. More
IOR Stock Earnings: Income Opportunity Realty Reported Results for Q2 2024
Income Opportunity Realty just reported results for the second quarter of 2024. More
NUTX Stock Earnings: Nutex Health Misses EPS, Beats Revenue for Q2 2024
NUTX stock results show that Nutex Health missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. More
